NASDAQ-GS · traded in Congress
Cytokinetics, CYTK
$64.6925 -0.9675 (-1.47%) Sep 25, 2026 4:49 AM ET
Market value$9.0B
P/E ratio-
Analyst target$107.00
52-week range-
Avg volume1,845,065
Dividend yieldN/A
Chart
Congress trades in CYTK
Members of Congress disclosed 1 transaction in CYTK in the filings we have processed.
| Traded | Member | Type | Amount | Filed |
|---|---|---|---|---|
| 06/30/2026 | Gilbert Cisneros CA31 | Purchase | $1,001 - $15,000 | 7/2/2026 filing |
Disclosed under the STOCK Act. Amounts are the ranges the law requires, filings can lag a trade by up to 45 days, and a disclosure is not evidence of wrongdoing. All congressional trades ›
Other companies
Price and key figures from Nasdaq's public quote data, refreshed through the day; the chart is live from TradingView. Congressional trades parsed from official House filings. Market information, not investment advice.